Satellos Bioscience Inc

NEW
STU:0IT (Canada)  
€ 0.39 -0.014 (-3.45%) Apr 8
At Loss
P/B:
3.52
Market Cap:
€ 67.22M ($ 74.17M)
Enterprise V:
€ 37.20M ($ 41.05M)
Volume:
-
Avg Vol (2M):
5.75K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.85
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -57
3-Year EPS without NRI Growth Rate -50
3-Year FCF Growth Rate -48.8

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.68
Quick Ratio 6.68
Cash Ratio 6.47

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -50.8
Name Current Vs Industry Vs History
ROE % -83.28
ROA % -75.62
ROIC % -823.88
3-Year ROIIC % -369.56
ROC (Joel Greenblatt) % -150147.37
ROCE % -83.28

Financials

STU:0IT's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Satellos Bioscience Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.153
Beta 0.77
3-Year Sharpe Ratio 0.34
3-Year Sortino Ratio 0.64
Volatility % 84.58
14-Day RSI 25.63
14-Day ATR (€) 0.021831
20-Day SMA (€) 0.4854
12-1 Month Momentum % 67.2
52-Week Range (€) 0.248 - 0.785
Shares Outstanding (Mil) 165.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Satellos Bioscience Inc Filings

Filing Date Document Date Form
No Filing Data

Satellos Bioscience Inc Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

Satellos Bioscience Inc Frequently Asked Questions

What is Satellos Bioscience Inc(STU:0IT)'s stock price today?
The current price of STU:0IT is €0.39. The 52 week high of STU:0IT is €0.79 and 52 week low is €0.25.
When is next earnings date of Satellos Bioscience Inc(STU:0IT)?
The next earnings date of Satellos Bioscience Inc(STU:0IT) is .
Does Satellos Bioscience Inc(STU:0IT) pay dividends? If so, how much?
Satellos Bioscience Inc(STU:0IT) does not pay dividend.

Press Release

Subject Date
No Press Release